Has Jessica Moran-Hansen, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,406 in general payments to Jessica Moran-Hansen, MD across 91 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jessica Moran-Hansen, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jessica Moran-Hansen, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jessica Moran-Hansen, MD

Otolaryngology · Omaha, NENPI 1528296209

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,568 of the $3,406 with a category attached, or 75.4%. It is spread thinly across 18 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations.

$3,406in general payments, 2019–2025

Across 91 payments — averaging $37.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intersect ENT, Inc.$637
Medical Device Business Services, Inc.$444
Regeneron Healthcare Solutions, Inc.$412
Optinose US, Inc.$291
Kyowa Kirin, Inc.$240
Stryker$235
plus $1K from 12 others

What the payments were for

Consulting fees$2407%
Travel & lodging$44413%
Food & beverage$2,56875%
Education$1545%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intersect ENT, Inc.	15	$637
Medical Device Business Services, Inc.	1	$444
Regeneron Healthcare Solutions, Inc.	12	$412
Optinose US, Inc.	15	$291
Kyowa Kirin, Inc.	1	$240
Stryker	6	$235
Sanofi	11	$231
Acclarent, Inc	6	$210
Medtronic(2 entities)	4	$166
Aerin Medical Inc.	7	$162
Inspire Medical Systems, Inc.	1	$132
GSK	5	$82
Itamar Medical Inc	1	$55
Amgen	2	$51
Hikma Pharmaceuticals USA	1	$17
Arbor Pharmaceuticals, Inc.	1	$15
AstraZeneca	1	$14
Kaleo, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,406 in reported general payments places this provider in the 85th percentile of 86 otolaryngology providers in Nebraska.

See all otolaryngology providers in Nebraska →

Medicare billing

Part B allowed, 2024

$136,908

Medicare patients

290

Services billed

1,321

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	179	$4,482
Budesonide	36	$2,922
Fluticasone Propionate	218	$2,640
Azelastine Hcl	95	$2,426
Ofloxacin	49	$1,289
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	11	$1,107
Montelukast Sodium	107	$410
Omeprazole	41	$360
Doxycycline Hyclate	33	$307
Azithromycin	45	$305
Mupirocin	32	$253
Ondansetron OdtOndansetron	23	$145
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	17	$145
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	24	$125
Methylprednisolone	11	$83

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Omaha

Rahul VarmanOmaha$13K
Daniel O'BrienOmaha$10K
Wallace DuffOmaha$8K
Tyler BlissOmaha$4K
Adam PleasOmaha$4K
Kyle StansiferOmaha$3K
Jason TalmadgeOmaha$3K
Thomas DoblemanOmaha$3K
Stanley SchackOmaha$3K
Paul SherrerdOmaha$3K

See the full list for Nebraska →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →